Healthcare Technology Report August 21, 2025
90% of drugs fail clinical trials.
Vivodyne is changing what happens before that point by testing treatments on 3D lab-grown human tissues instead of animals. Built by CEO Andrei Georgescu and his team, the platform runs robotic experiments on over 100,000 engineered tissues every two weeks, capturing safety, efficacy, and immune response data that’s built for human biology.
Each robotic run generates more human-specific data than all U.S. trials combined. Vivodyne’s platform spans 20 organ types, models diseases like cancer, fibrosis, and autoimmunity, and supports thousands of patient profiles at once....
Today's Sponsors
Today's Sponsor